Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA204311-001

ABACAVIR SULFATE AND LAMIVUDINE(ABACAVIR SULFATE)

Nucleoside and nucleotide reverse transcriptase inhibitors; Antivirals for treatment of HIV infections, combinations

Manufacturer: PHARMOBEDIENT

FDA Approval: 22/12/2023

Route: ORAL · TABLET, FOR SUSPENSION

Active Ingredients

ABACAVIR SULFATE EQ 60MG BASE; LAMIVUDINE 30MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR SULFATE AND LAMIVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Ask about ABACAVIR SULFATE AND LAMIVUDINECreate Free Account

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.